1 Min Read
Feb 24 (Reuters) - Elanix Biotechnologies AG:
* Capital increase successfully placed, gross issuing proceeds amount to some 4.76 million euros ($5.04 million) Source text for Eikon: Further company coverage: ($1 = 0.9452 euros) (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.